Dimercaptosuccinic Acid: Summary of Evidence.

Q4 Medicine

International journal of pharmaceutical compounding Pub Date : 2023-03-01

Jamarius Carvin, Tara Thompson

引用次数: 0

Abstract

Dimercaptosuccinic acid, or succimer, is an oral, heavy-metal chelating agent used to treat lead and heavy-metal poisoning. Although the drug is mainly used for the treatment of lead intoxication, initial data has shown encouraging results for the treatment of mercury and arsenic poisoning as well. This article focuses on the use of dimercaptosuccinic acid as a chelating agent and provides some general information on dimercaptosuccinic acid.

本刊更多论文

二巯基琥珀酸:证据综述。

二巯基琥珀酸是一种用于治疗铅和重金属中毒的口服重金属螯合剂。虽然该药主要用于治疗铅中毒，但初步数据显示，在治疗汞和砷中毒方面也有令人鼓舞的结果。本文重点介绍了二巯基琥珀酸作为螯合剂的应用，并提供了二巯基琥珀酸的一些一般信息。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International journal of pharmaceutical compounding Medicine-Medicine (all)

CiteScore

0.40

自引率

0.00%

发文量

期刊介绍： The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly, scientific and professional journal emphasizing quality pharmaceutical compounding. IJPC is the only publication that covers pharmaceutical compounding topics relevant and necessary to empower pharmacists to meet the needs of today"s patients. No other publication features hands-on, how-to compounding techniques or the information that contemporary pharmacists need to provide individualized care.